About JCCT
JCCT is a Healthcare company based in Lenexa (United States) founded in 2005 by Casey Johnson, Mazen Zari, and Nathan Arthur. It operates as a CRO focused on early end stage clinical trial services. Its chief executive is Mazen Zari. Its website jcct.com draws about 26 thousand monthly visits. JCCT offers products and services including Clinical Trial Services and Vaccine Trials. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Medpace, Lambda Therapeutic, Dhiti Life Sciences, Diacrin and Ascada Research and 2 more.
Company details
JCCT, established in 2005, excels in providing healthcare solutions, biopharma outsourcing, cro, clinical development, and full service. CRO focused on early end stage clinical trial services. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Investors
Products & Services of JCCT
JCCT offers a comprehensive portfolio of products and services, including Clinical Trial Services and Vaccine Trials.
Conducts studies for new medical treatments and participant compensation.
Tests vaccines for diseases like norovirus and influenza.
Funding Insights of JCCT
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of JCCT with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | – | Private Equity Round | – | FFL Partners | – |
1 investors in total: 1 institutional.
Investors in JCCT
JCCT has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include FFL Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Lower middle market investments are targeted by FFL Partners. | 1997 | fflpartners.com | San Francisco, United States |
Investor details for JCCT
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of JCCT
4 people are tracked at JCCT (4 in leadership).
| Name | Role | Group |
|---|---|---|
Casey Johnson | Co-Founder | Leadership |
Mazen Zari | Co-Founder & Co-CEO | Leadership |
Nathan Arthur | Co-Founder & Co-CEO | Leadership |
Daniel White | CEO | Leadership |
Complete people profiles for JCCT
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of JCCT
2 dated milestones of JCCT across 18 years, from founding to its latest funding, stage changes and deals.
- Founded JCCT is founded.
- Funding First funding round.
Competitors of JCCT
JCCT has 7 listed competitors in our database. They include Medpace, Lambda Therapeutic, Dhiti Life Sciences, Diacrin and Ascada Research, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medpace.com | 1992 | Cincinnati, United States | – | – | A range of clinical research services is offered by Medpace. | |
| lambda-cro.com | 1998 | Ahmedabad, India | – | 1,011 | CRO with operations in India, US, Poland, Canada and UK. Winner of Frost & Sullivan 'CRO of the Year' - 2010 | |
| dhitilifesciences.com | 2010 | Delhi, India | – | 21 | Biotechnology company offering in vitro diagnostic products for healthcare sector | |
| diacrin.com | 1989 | Boston, United States | – | – | Educational programs are provided by Diacrin since 1989. | |
| ascadaresearch.org | 2021 | Fullerton, United States | – | 31 | Performs clinical research trials to evaluate investigational drugs and devices. | |
| neomedlabs.com | 2015 | Laval, Canada | – | – | Contract research organisation offering immunology services for vaccines and immunotherapies | |
| tandemclinicalresearch.com | 2016 | Marrero, United States | – | – | Phase I-IV clinical development services are provided by this CRO. |
Detailed competitors of JCCT
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of JCCT
The website of JCCT (jcct.com) receives about 26.5K visits a month.
- Monthly visits26.5K
▼ 12.4% vs previous month
Websites whose visitors overlap most with JCCT. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| youtube.com | 100% | 30.4B | #2 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as JCCT (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jcct
Complete news archive for JCCT
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JCCT
JCCT was founded in 2005 and raised its 1st funding round 18 years after it was founded.
JCCT is headquartered in Lenexa, United States. It is registered at Lenexa, Kansas, United States.
Mazen Zari is the current CEO of JCCT. They have also founded this company.
JCCT, established in 2005, excels in providing healthcare solutions, biopharma outsourcing, cro, clinical development, and full service. CRO focused on early end stage clinical trial services. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
JCCT's top competitors include Medpace, Lambda Therapeutic and Dhiti Life Sciences.
JCCT offers Clinical Trial Services and Vaccine Trials.
JCCT has 1 investor. Key investors include FFL Partners.